The last time I wrote about Centessa Pharmaceuticals plc (NASDAQ:CNTA), it was in a Seeking Alpha article entitled “Centessa: Hemophilia B Data Readout In 2024 is Major Turning Point.” One of the ...

Royal Dutch Shell had a strong 3Q in relation to the company’s almost $190 billion market cap, with strong earnings despite a lofty valuation. The company had $6 billion in adjusted earnings and $14.7 ...